Cleveland Crain’s Article: MCM Capital Partners Sells Dexmet

Cleveland, OH – MCM Capital Partners ("MCM"), a micro-cap private equity firm based in Cleveland, Ohio, is pleased to announce its acquisition of Octex, based in Sarasota, FL. Octex is an ISO 13485-certified custom injection molder specializing in highly engineered thermoplastic components for medical device, life sciences, and technically demanding industrial customers. The Company operates...

Cleveland, OH, February 17, 2025 - MCM Capital Partners (“MCM”), a lower middle market private equity firm, is pleased to announce the sale of Zinkan Enterprises, rebranded as ChemREADY (“Zinkan”), a leading provider of chemicals, equipment, and services used for maintaining safe and compliant water quality processes to Plexus Capital, headquartered in Charlotte, NC.  This...

DENVER, CO – AIM Processing, with support from MCM Capital Partners, has acquired Technical Molded Products, a move that solidifies AIM's position as one of the leading injection molders serving manufacturers in the western United States. This strategic acquisition enhances AIM's capabilities and expands its customer base in key industries. AIM Processing, which specializes in...

MCM Capital Partners (“MCM”), a lower middle market private equity fund, is pleased to announce the sale of RMB Products (“RMB”), a precision manufacturer of highly engineered thermoplastic components utilizing rotational molding, rotational lining and 3D printing processes. RMB nearly doubled both revenues and EBITDA during our partnership, resulting in an attractive outcome for MCM,...